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Abstract
More than a million childhood diarrhoeal episodes occur worldwide each year, and in developed countries a considerable
part of them are caused by viral infections. In this study, we aimed to search for genetic variants associated with diarrhoeal
disease in young children by meta-analyzing genome-wide association studies, and to elucidate plausible biological mecha-
nisms. The study was conducted in the context of the Early Genetics and Lifecourse Epidemiology (EAGLE) consortium. Data
about diarrhoeal disease in two time windows (around 1 year of age and around 2 years of age) was obtained via parental
questionnaires, doctor interviews or medical records. Standard quality control and statistical tests were applied to the 1000
Genomes imputed genotypic data. The meta-analysis (N¼5758) followed by replication (N¼3784) identified a genome-wide
significant association between rs8111874 and diarrhoea at age 1 year. Conditional analysis suggested that the causal variant
could be rs601338 (W154X) in the FUT2 gene. Children with the A allele, which results in a truncated FUT2 protein, had lower
risk of diarrhoea. FUT2 participates in the production of histo-blood group antigens and has previously been implicated in
the susceptibility to infections, including Rotavirus and Norovirus. Gene-set enrichment analysis suggested pathways related
to the histo-blood group antigen production, and the regulation of ion transport and blood pressure. Among others, the gas-
trointestinal tract, and the immune and neuro-secretory systems were detected as relevant organs. In summary, this
genome-wide association meta-analysis suggests the implication of the FUT2 gene in diarrhoeal disease in young children
from the general population.
Introduction
Diarrhoea, defined as three or more loose stools within the previ-
ous 24 h, is probably one of the most common symptoms in chil-
dren, with an estimated 1370 million annual episodes in children
younger than 5 years in 2010 (1). Two percent of these episodes
progress to severe disease, and 700 000 episodes lead to death,
mainly in low-income countries (1). In developed countries, diar-
rhoeal disease is a common reason for attendance at a general
practitioner, especially in children under 5 years of age (2).
Several pathogens can account for infections associated
with diarrhoeal disease, including viruses, bacteria and para-
sites. The GEMS study (Global Enteric Multicenter Study), con-
ducted as a case–control study in seven African and Asian sites,
identified Rotavirus, Cryptosporidium, enterotoxigenic Escherichia
coli, and Shigella as most responsible attributable pathogens for
cases of moderate-to-severe diarrhoea (3). In developed coun-
tries, improvements in public health infrastructure (water and
sewage management), has caused a shift in the main causes of
acute paediatric diarrhoea, moving from bacterial and parasite
aetiologies to viruses. Rotavirus is the primary cause of diar-
rhoeal disease globally, and is responsible for almost half of the
gastroenteritis cases requiring hospitalization in Western coun-
tries, followed by Norovirus, Adenovirus and Salmonella (4). The
peak age for infection with Rotavirus is between 3 months and 2
years, coinciding with reduced protection by transplacental
transfer of maternal antibodies (5) and the end of the lactation
period (6). At the age of 5, almost all children have been infected
with Rotavirus, and progressively develop natural immunity
against this virus (7). Enteric pathogens damage small bowel
enterocytes and cause impaired intestinal absorption, low grade
fever and watery diarrhoea as a result of the deregulation of ion
transport and stimulation of the enteric nervous system (8,9). In
children, factors other than enteric pathogens can cause
diarrhoea, including among others extra-intestinal infections,
intolerances or food allergies (10), nutrient deficiencies, antimi-
crobials, or hereditary diseases, such as cystic fibrosis, but these
represent a small proportion of all cases of diarrhoea.
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The exposure to infectious agents plays a major role in the
acquisition of the pathogen and development of diarrhoeal dis-
ease. However, not all individuals are equally susceptible to in-
fection, and if infected, they may differ in their immunological
response. Host genetic factors can explain part of the differ-
ences in susceptibility and response to infection. In a study on
families with adopted children, it was shown that premature
death due to infection of the biological parent, but not of the
adopting parent, increased the relative risk of death due to in-
fection in the adopted child by 5.8-fold, a higher risk than ob-
served for vascular disease or cancer (11). Twin studies on
infectious diseases have shown higher correlation between
monozygotic than dizygotic twins (12–14). Heritability for early
childhood diarrhoea was estimated to be 54% in a pedigree-
based design in Brazil (15).
Candidate gene studies for infectious gastroenteritis have
identified genetic variants in genes involved in the innate and
acquired immune responses and in genes that participate in the
production of histo-blood group antigens (HBGAs), which serve
as receptors for numerous pathogens. In particular, the non-
secretor phenotype, associated with null or inactivating
mutations in FUT2 gene resulting in a lack of certain antigens in
secretions and epithelial mucosa, confers strain-specific protec-
tion against Norovirus (16–18) and Rotavirus (19). A review of the
associations between enteric pathogens and genetic variants
can be found elsewhere (20,21).
The aims of the present study were: (1) to identify genetic
variants that confer susceptibility to diarrhoeal disease in
young children from the general population of developed coun-
tries through a genome-wide association meta-analysis, and (2)
to elucidate potential biological mechanisms involved in diar-
rhoeal disease using pathway analysis approaches.
Results
Sample
Four different traits, any diarrhoea and doctor’s confirmed diag-
nosis of diarrhoea around 1 year of age (D1Y and DD1Y) and
around 2 years of age (D2Y and DD2Y), were explored. Samples
analyzed for each outcome in the discovery and in the replica-
tion phase are shown in Table 1. Information on diarrhoea was
collected through questionnaires, doctor interviews or medical
records (see Supplementary Material, Annex A).
In the discovery phase, 46.8% of the children had had at least
one diarrhoeal episode around the age of 1 year (D1Y), while
this proportion decreased to 21.8% for the cases diagnosed by a
doctor (DD1Y). The proportions for children around the age of
two years were 50.9% for diarrhoeal disease (D2Y) and 20.6% for
doctor’s diagnosis (DD2Y). Similar frequencies of diarrhoea
were observed in the replication samples. The number of diar-
rhoea cases in Generation R and CHOP was lower than in other
cohorts. For some of the diarrhoeal definitions, ALSPAC and
GINIplus showed higher proportion of cases among males than
among females.
Discovery phase
The Q–Q plots and the Manhattan plots for each outcome are
shown in Figure 1 (D1Y) and in the Supplementary Material,
Figures S1 (DD1Y), S2 (D2Y) and S3 (DD2Y). Genomic inflation
factor, lambda (k), ranged from 0.9952 to 1.0031.
For D1Y, the meta-analysis of 5,758 samples revealed a
genome-wide significant variant, rs8111874, at 19q13.33 [odds
ratio (OR) (95% confidence interval [CI]) ¼ 1.32 (1.21–1.44); P-
value¼ 1.06E09] (Table 2 and Fig. 2)]. This lead SNP was also
nominally associated with DD1Y [OR (95%CI) ¼ 1.26 (1.14–1.39);
P-value¼ 1.05E05] and with DD2Y [OR (95%CI) ¼ 1.32 (1.17–
1.48); P-value¼ 4.6E07] and with D2Y [OR (95%CI) ¼ 1.08 (1.00–
1.18); P-value¼ 6.56E02]. In D1Y, the G allele increased the risk
of diarrhoeal disease in all the studies (P-value for
heterogeneity¼ 2.99E02, Table 2).
Another locus at 4q21.23, was associated with DD1Y at
genome-wide significance [N¼ 6403, OR (95%CI) ¼ 1.31 (1.19–
1.44); P-value¼ 2.92E08] (Supplementary Material, Table S1).
The lead variant, rs1481779, was located in an intron of
ARHGAP24 gene. This variant was also nominally associated
with D1Y [OR (95%CI) ¼ 1.09 (1.01–1.19); P-value¼ 3.7E02], but
not with D2Y or DD2Y.
Variants with a P-value< 1E05 are shown in Table 2 (D1Y)
and in Supplementary Material, Tables S1 (DD1Y), S2 (D2Y) and
S3 (DD2Y). With the exception of the signal at 19q13.33, no ma-
jor overlap was observed among the suggestive variants for
each outcome (data not shown). A description of the potential
function of the genetic variants and genes in each loci detected
at a P-value< 1E05 can be found in Supplementary Material,
Tables S4–S7.
Replication phase
Seventy-two loci (P-value< 1E-05 in any of the four diarrhoea
definitions) were followed for replication in an independent
dataset (Table 1). After multiple-testing adjustment, the SNP
rs8111874 at chromosome 19q13.33 was associated with D1Y
[replication: OR (95%CI) ¼ 1.25 (1.13–1.39); P-value¼ 1.69E05]
(Table 2), and it was nominally associated for the other diar-
rhoea outcomes (Fig. 2). Other variants at the same locus were
also associated with DD1Y and DD2Y (Supplementary Material,
Tables S1 and S3). None of the variants in other loci replicated,
and neither of them reached genome-wide significance in the
combined analyses. Results of the replication phase can be
found in Table 2 (D1Y) and in Supplementary Material, Tables
S1 (DD1Y), S2 (D2Y) and S3 (DD2Y).
Chromosome 19 locus: FUT2 gene
The regional association plot of rs8111874 at 19q13.33 shows a
linkage disequilibrium block that overlaps several genes, includ-
ing FUT2 (Fig. 3A). FUT2 participates in the production of histo-
blood group antigens (HBGAs) and contains a stop mutation
(rs601338, W154X) known to confer protection against certain in-
fections. We conditioned the top SNP at 19q13.33 (rs8111874) on
the stop mutation (rs601338) and vice versa: the odds ratios from
these analyses were attenuated (Table 3). After conditioning to
rs601338, no secondary signals were observed in the region (win-
dow size 1 Mb) (Fig. 3B). The forest plots for rs601338 (W154X) are
shown in Supplementary Material, Figure S4.
Enrichment analysis
Two prediction programs, the Meta-Analysis Gene-set
Enrichment of variaNT Associations (MAGENTA) and the Data-
driven Expression Prioritized Integration for Complex Traits
(DEPICT) were used to investigate gene-sets enriched among
the variants with the lowest P-values. Using MAGENTA, the
‘KEGG_GLYCOSPHINGOLIPID_BIOSYNTHESIS_GLOBO_SERIES’
gene-set was identified in DD2Y at a 5% False Discovery Rate
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(FDR) (Supplementary Material, Table S8). Six out of 14 genes of
this pathway had SNPs in the 95th percentile of lowest P-values.
This gene-set was also weakly associated with diarrhoea at age
1 year (D1Y). Other gene-sets with nominal evidence are listed
in Supplementary Material, Table S8, including the ’KEGG_
GLYCOSPHINGOLIPID_BIOSYNTHESIS_GANGLIO_SERIES’ and
the blood pressure regulatory gene-set ‘KEGG_RENIN_
ANGIOTENSIN_SYSTEM’.
The top 10 gene-sets detected with DEPICT for each outcome
are shown in Supplementary Material, Table S9. The gene-sets
‘ENSG00000147955—SIGMAR1 PPI subnetwork’ (involved in ion
channels regulation and modulation of neurotransmitter re-
lease), ‘MP:0001675—abnormal ectoderm development’,
‘GO:0007492—endoderm development’ and ‘ENSG00000140612—
SEC11A PPI subnetwork’ (component of the microsomal signal
peptidase complex) remained after multiple-testing for DD1Y.
Genetic variants showing suggestive P-values were linked to
genes with enriched expression in the gastrointestinal tract
(D1Y), in the immune system (DD1Y) and in the neuro-secretory
system (D2Y), among others (Supplementary Material, Table S10).
Exclusion of genetic variants in 1 Mb around the FUT2 locus gave
similar gene-sets and tissue/organs, but P-values were attenu-
ated (data not shown).
Overlap with known variants and genes for related
diseases
We compared the results from this study with variants reported
in the literature as associated with inflammatory bowel disease
(IBD) risk (22) and with viral infection and response to vaccina-
tion (23–36). Nine out of the 162 variants identified in IBD were
nominally associated with D1Y (Supplementary Material, Table
S11). Two of these variants passed the multiple-testing correc-
tion: one of them located in the FUT2 gene (P-value¼ 4.67E09,
opposite effect direction), and the other one in CARD11 locus (P-
value¼ 1.52E05, same effect direction). In addition, one out of
139 variants associated with infections was also associated with
D2Y after correction for multiple-testing (Supplementary
Material, Table S12). Specifically, the A allele of rs17793829, lo-
cated in TTC7B gene, was associated with higher anti
Cytomegalovirus IgG titer (31) and higher risk for D2Y (P-value¼ 2.
12E-04). Finally, we evaluated 86 genes retrieved from OMIM
Table 1. Samples included in the study at age 1 year and at age 2 years by diarrhoeal disease definition and study phase
Age 1 year
Diarrhoea (D1Y) Doctor diagnosis of diarrhoea (DD1Y)
Cohort Assessment
(period in months)a
N
total
N
cases
%
cases
Cohort Assessment
(period in months)a
N
total
N
cases
%
cases
Discovery ALSPAC (Disc)d Questionnaire (6–18) 3363 2001 59.5 ALSPAC (Disc)d Questionnaire (6–18) 3363 893 26.6
Generation R Questionnaire (6–12)c 2033 469 23.1 Generation R Questionnaire (6–12)c 2033 179 8.8
INMA_SAB Questionnaire (6–14) 362 223 61.6 COPSAC2000 Doctor interview (6–12) 345 81 23.5
LISAplus Questionnaire (6–12) 662 186 28.1
TOTAL 5758 2693 46.8 TOTAL 6403 1339 21.8
Replication ALSPAC (Repl) Questionnaire (6–18) 3361 2047 60.9 ALSPAC (Repl) Questionnaire (6–18) 3361 871 25.9
MoBa Questionnaire (6–18)c 407 255 62.6 COPSAC2010 Doctor interview (6–12) 547 244 44.6
INMA_VAL Questionnaire (0–12) 334 149 44.6
CHOPb Medical records (6–18) 3223 147 4.6
TOTAL 3768 2302 61.1 TOTAL 7465 1411 18.9
Age 2 years
Diarrhoea (D2Y) Doctor diagnosis of diarrhoea (DD2Y)
Cohort Assessment
(period in months)a
N
total
N
cases
%
cases
Cohort Assessment
(period in months)a
N
total
N
cases
%
cases
Discovery ALSPAC (Disc)d Questionnaire (18–30) 3189 1746 54.8 ALSPAC (Disc) Questionnaire (18–30) 3189 514 16.1
Generation R Questionnaire (18–24)c 2058 943 45.8 Generation R Questionnaire (18–24)c 2058 190 9.2
INMA_SAB Questionnaire (12–24) 361 166 46 COPSAC2000 Doctor interview (18–24) 319 86 27
LISAplus Questionnaire (18–24) 667 200 30
TOTAL 5608 2855 50.9 TOTAL 6233 990 20.6
Replication ALSPAC (Repl)d Questionnaire (18–30) 3187 1759 55.2 ALSPAC (Repl) Questionnaire (18–30) 3187 485 15.2
INMA_VAL Questionnaire (12–14) 329 213 64.7 COPSAC2010 Doctor interview (18–24) 518 271 52.3
GINIplusd Questionnaire (12–24) 794 328 41.3
CHOPb Medical records (18–30) 3223 190 5.9
Total 3516 1972 56.1 Total 7722 1274 16.5
aPeriod referred in the questionnaire, medical record or doctor interview.
bOnly children not vaccinated against Rotavirus were included.
cIt refers specifically to gastric flu or gastroenteritis.
dStatistically significant differences in the proportions of diarrhoeal disease among males and females (P-value<0.05) [ALSPAC-D1Y-Discovery: 61.2% males versus
57.7% females; ALSPAC–DD1Y-Discovery: 29.2% versus 23.8%; ALSPAC-D2Y-Discovery: 56.6% versus 52.8%; ASLPAC-D2Y-Replication: 58.5% versus 51.7%; and GINIplus-
DD2Y-Replication: 46.7% versus 36.0%].
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(Online Mendelian Inheritance in Man) with the entry ‘diar-
rhoea’. None of them was associated with childhood diarrhoeal
disease after multiple testing correction (Supplementary
Material, Table S13).
Discussion
This study suggested the implication of the FUT2 locus in the
diarrhoeal risk and provided evidences supporting the role of
the histo-blood group antigen (HBGA) production and the regu-
lation of ion transport pathways. The gastrointestinal tract and
the immune and neuro-secretory systems were detected as rel-
evant organs.
The genome-wide association meta-analysis followed by
replication identified an association between rs8111874 map-
ping to the 19q13.33 locus and diarrhoea around 1 year of age
(D1Y). Although with different strength, the association was
also observed in all the different diarrhoeal outcomes investi-
gated. The rs8111874 variant is located in an intronic region of
the NTN5 (Netrin 5) and SEC1P (Secretory Blood Group 1,
Pseudogene) genes and close to FUT2, previously associated with
susceptibility to infection. FUT2 encodes the Fucosyltransferase 2
enzyme that participates in the production of histo-blood group
antigens (HBGAs) by catalyzing the addition of a fucose residue
in a1,2 linkage to the galactose of O- or N-glycoproteins and
globo-, ganglio- or lacto-series of glycolipids (37). The FUT2 en-
zymatic activity is polymorphic, exhibiting the non-secretor
phenotype (lack of certain antigens in the gut and epithelial
mucosa) when inactivating mutations are present in the FUT2
gene. The most common FUT2 inactivating variant in
Caucasians (Europeans and Iranians) and in Africans, is the
stop mutation W154X (rs601338), while in Asians it is the mis-
sense variant A385T (rs1047781) (38). In order to investigate
whether the signal observed at 19q13.33 locus could be caused
by the stop mutation W154X (rs601338), the lead SNP in the re-
gion (rs8111874) was conditioned to the inactivating mutation
and vice versa. The magnitudes of the effects of the conditional
analyses were substantially attenuated, suggesting the pres-
ence of one single association signal. Children with the A allele
at rs601338 (W154X), which results in a truncated FUT2 protein
and the non-secretor phenotype, had lower risk of diarrhoeal
disease during the first years of life. In agreement with our re-
sults from a population based design, the non-secretor pheno-
type has been associated with protection against Rotavirus (19),
Norovirus (16–18) and Helicobacter pylori (39,40) in small settings
of very well characterized hospitalized subjects. It is known that
Norovirus (41) and Rotavirus (42–44) bind to the antigen associ-
ated with the FUT2 secretor phenotype to enter the cells. In con-
trast, the FUT2 non-secretor phenotype has been associated
with higher risk of urinary tract infections (45), acute pyelone-
phritis (46), oral or vaginal Candida infections (12,47,48),
Haemophilus influenza (49), Neisseria meningitides and Streptococcus
pneumoniae infections (50). In addition, non-secretor individuals
are at a higher risk of developing autoimmune diseases such as
inflammatory bowel disease (22,51), psoriasis (52,53), and
Behcet’s disease (54) and they also have higher vitamin B12
plasma levels (55,56). Recently, the non-secretor phenotype has
been associated with gut microbiota at both the compositional
and functional level (57). Non-secretors have lower species rich-
ness than the secretors (58), and the secretion status is a modi-
fying factor for gut microbiota composition in Chron’s disease
(59). Fucose from fucosylated proteins synthesized by FUT2 in
response to the activation of the innate immunity can be used
by microbes as an energy source, and this has been shown to re-
duce bacterial infection and downregulate the expression of vir-
ulence genes (60,61). Fucosylation appears to be a protective
mechanism to maintain host-microbial interactions during
pathogen-induced stress, but on the other hand, it facilitates vi-
ral entrance into the cells.
Although the non-secretor phenotype related mutation in
FUT2 (W154X, rs601338) is the most likely causal variant of child-
hood diarrhoeal disease at 19q13.33 locus, the functional role of
other variants in the region cannot be completely ruled out based
on statistical analysis. Another variant, located in an intron of
the ARHGAP24 gene (rs1481779), reached genome-wide signifi-
cance in DD1Y, but it could not be replicated. ARHGAP24 codes a
Rho GTPase-activating protein involved in cell polarity, cell mor-
phology and cytoskeletal organization; and SNPs in it have been
reported to be associated with blood pressure regulation (62).
In order to gain insight into potential molecular mechanisms
underlying diarrhoeal disease in young children, we performed
enrichment studies. The analysis using two different programs
identified several gene-sets at 5% FDR. The
‘KEGG_GLYCOSPHINGOLIPID_BIOSYNTHESIS-GLOBO_SERIES’
gene-set contains genes related to the production of histo-blood
group antigens (HBGAs) from globo-series glycolipids and was at
least nominally associated with several definitions of diarrhoea
(D1Y and DD2Y). Apart from FUT2, already discussed above,
A4GALT (Alpha 1,4-Galactosyltransferase) in the gene-set also showed
some evidence of association with D2Y. A similar gene-set,
‘KEGG_GLYCOSPHINGOLIPID_BIOSYNTHESIS-GANGLIO_SERIES’,
was also identified.
A second gene-set consisting of a SIGMAR1 protein interac-
tion network (ENSG00000147955—SIGMAR1 PPI subnetwork)
Figure 1. (A) Quantile-quantile (Q-Q) plots showing the probability values from
GWAS meta-analysis of diarrhoeal disease at age 1 year (D1Y). The line indicates
the distribution under the null hypothesis. Lambda value is shown. (B)
Manhattan plot of the GWAS meta-analysis of diarrhoeal disease at age 1 year
(D1Y). The x-axis represents the autosomal chromosomes and the y-axis repre-
sents –log10(P). The dotted line indicates genome-wide significance
(P¼5.00E08), and the dashed line indicates suggestive genome-wide signifi-
cance (P¼1.00E05).
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was detected for DD1Y. SIGMAR1 is an endoplasmic reticulum-
resident two-transmembrane chaperone that regulates voltage-
gated ion channels including calcium, sodium and potassium
channels (63). We also identified other pathways related to
hydro-electrolytic balance such as the ‘KEGG_RENIN_
ANGIOTENSIN_SYSTEM’, the ‘GO:0005227—calcium activated
cation channel activity’, the ‘GO:0015299—solute:hydrogen anti-
porter activity’ and the ‘ENSG00000187446—ENSG00000187446
PPI subnetwork’, related to cell pH regulation by controlling
plasma membrane-type Na(þ)/H(þ) exchange activity (64).
Deregulation of transport of ions is a central mechanism in the
pathophysiology of enteric pathogens (8,9). Host genetic vari-
ants might compensate or accelerate watery stools after enteric
infection.
Other gene-sets related to ectoderm and endoderm develop-
ment were observed for DD1Y: ‘MP:0001675—abnormal ecto-
derm development’ and ‘GO:0007492—endoderm development’.
The endoderm is the inner most germ layer that develops into
the gastrointestinal tract, the lungs and associated tissues.
Finally, the ‘ENSG00000140612—SEC11A PPI subnetwork’ was
also identified. SEC11A is a component of the microsomal signal
peptidase complex which removes signal peptides from nascent
proteins as they are translocated into the lumen of the endo-
plasmic reticulum.
As expected, the gastrointestinal tract and the immune sys-
tem were detected as relevant organs for diarrhoeal disease. The
gastrointestinal tract was identified with the general definition
of diarrhoea around 1 year of age (D1Y); while doctor diagnosis
of diarrhoeal disease (DD1Y), probably more related to severe
cases, highlighted the immune system. In addition, the neuro-
secretory system was found to be associated with diarrhoea
around 2 years of age (D2Y). The central nervous system com-
municates with the intestine through the hypothalamic–pitui-
tary–adrenal axis. The autonomic enteric nervous system
regulates gastrointestinal motility, secretion, barrier function
and inflammatory response at the mucosa (65). Indeed, gene-
sets related to neurotransmission were also identified:
‘Panther—Nicotinic_acetylcholine_receptor_signaling_pathway’,
‘GO:0090278—negative regulation of peptide hormone secretion’
or a protein network regulating neurotransmitter release
Figure 2. Forest plots for rs8111874 at 19q13.33 for the four diarrhoeal outcomes: (A) Diarrhoea at age 1 year (D1Y); (B) Doctor diagnosis of diarrhoea at age 1 year
(DD1Y); (C) Diarrhoea at age 2 years (D2Y); (D) Doctor diagnosis of diarrhoea at age 2 years (DD2Y). In the vertical panel, the studies participating in the discovery or rep-
lication phase are presented. In the horizontal lines, the sizes of the boxes represent precision and the lines the confidence intervals. The diamond shapes represent
the pooled effect estimates, for both the fixed- and random-effect models. The horizontal axis shows the scale of the effect estimates. The effect allele is G, and the
other allele is A.
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Figure 3. (A) Regional association of 19q13.33 locus (top SNP: rs8111874, chr19:49168942) with diarrhoeal disease at age 1 year (D1Y) (N ¼ 5758). The top variant is indi-
cated with a diamond in purple and the flanking variants in circles, coloured according to their linkage disequilibrium (LD). Variant rs601338 is shown in a black circle.
The plot was constructed using the 1000 Genomes CEU population (Northern and Western European ancestry). (B) Regional association of 19q13.33 locus (top SNP:
rs8111874, chr19:49168942) with diarrhoeal disease at age 1 year (D1Y) conditioned to rs601338 (N ¼5758). The associations of the genetic variants in the region were
attenuated.
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‘ENSG00000147955—SIGMAR1 PPI subnetwork’. Several organs,
such as the urogenital and musculoskeletal systems, not a priori
of relevance for diarrhoeal disease, were identified for DD2Y.
Finally, given the known opposite effect of the FUT2 locus in
infectious diseases compared to autoimmune diseases, we de-
cided to compare our GWAS results with the results reported in
the largest GWAS of IBD, for which an infectious component
has been suspected (22). Besides the FUT2 locus, where we con-
firmed the opposite direction of the association, the same allele
in a SNP at CARD11 locus, was associated with higher risk of IBD
and higher risk of D1Y. CARD11 (Caspase Recruitment Domain
Family, Member 11) is involved in the co-stimulatory signal es-
sential for T-cell receptor (TCR)-mediated T-cell activation. We
also compared our results with several GWAS of viral infections
and response to vaccination (23–36). The TTC7B (Tetratricopeptide
Repeat Domain 7B) locus, associated with higher anti
Cytomegalovirus IgG titer (31), a marker of either new infection or
frequent viral reactivation, was associated with higher risk for
D2Y. Other studies have reported the participation of TTC7B in
Chikungunya virus infection (66), and a paralog of TTC7B, TTC7A,
has been implicated in a rare hereditary disease characterized
by intestinal obstructions and profound immune defects (67).
The main limitations of the study are the low specificity of
the phenotype definition, and the lack of underlying etiological
information for the defined episodes. Information on diarrhoeal
disease was retrieved using standard epidemiological tools for
population-based birth cohort studies: questionnaires (ALSPAC,
Generation R, GINIplus and LISAplus, INMA_VAL and
INMA_SAB and MoBa), medical interviews (COSPAC) and medi-
cal records (CHOP). Apart from medical record definitions, the
most specific assessment of infectious gastroenteritis was in
Generation R and in MoBa studies, where the questionnaires in-
cluded the following statement: ‘infections of the stomach/in-
testine or gastric flu’. In fact, Generation R showed a low
number of diarrhoeal disease cases and a high effect of the vari-
ant at FUT2 locus, suggesting less misclassification problems.
We acknowledge that misclassification and heterogeneity (i.e.
infection by different underlying aetiologies, bacterial species or
viral strains or seasonality) may have decreased the statistical
power in the discovery phase and might explain the lack of rep-
lication of suggestive hits besides the FUT2 locus. Furthermore,
cohorts with different study designs participated in the analy-
ses: mainly population-based birth cohorts, but also a random
collection of paediatric children from a hospital centre (CHOP,
replication), and a population-based birth cohort of infants born
to mothers with a history of asthma (COPSAC2000, discovery).
The potential relationship between asthma and infection dis-
eases might have affected the associations. To the best of our
knowledge, there are no population-based studies of this sam-
ple size with molecular diagnosis of infectious gastroenteritis.
Although we analyzed all available samples from the EArly
Genetics and Life course Epidemiology (EAGLE) consortium fol-
lowing a flexible inclusion criteria the sample size is still inter-
mediate for genome-wide scale studies. Therefore, increasing
the specificity of the outcome and the sample size in
population-based designs might reveal novel loci for childhood
diarrhoeal disease and confirm the role of host genetics in infec-
tious diseases during the first years of life. Finally, although
diarrhoeal disease in young children is mainly caused by
Rotavirus, which is a wide-spread virus producing seasonal
break-outs in all the countries included in this study, we cannot
completely exclude the possibility that the identified variants
reflect different levels of exposure to the virus, rather than a
higher susceptibility to infection.
In summary, the genome-wide association meta-analysis of
diarrhoeal disease in children suggested the implication of the
FUT2 locus at the population level, and has pointed to W154X
(rs601338) as the most likely causal variant. The histo-blood
group antigen (HBGA) production and the regulation of ion
transport were plausible underlying biological mechanisms ac-
counting for part of the host genetic variability of diarrhoeal
disease.
Materials and Methods
Sample and diarrhoeal disease definition
This study was performed within the framework of the Early
Genetics and Life course Epidemiology (EAGLE) Consortium
(http://www.wikigenes.org/e/art/e/348.html) and it was divided
in two phases: discovery and replication. The following
population-based birth cohorts or studies settled up in devel-
oped countries participated in the discovery and/or replication
phases (Table 1): the Avon Longitudinal Study of Parents And
Children (ALSPAC), the Children’s Hospital of Philadelphia
(CHOP) study, the Copenhagen prospective studies on asthma
Table 3. Conditional analysis at 19q13.33 locus (rs8111874 and rs601338)
Crude results
for rs8111874
Results for rs8111874
conditioned to rs601338
Marker rs_number EA NEA EAF IMP Outcome OR lCI uCI P-value N OR lCI uCI P-value
19:49168942:SNP rs8111874 G A 0.57 0.82-0.93 D1Y 1.32 1.21 1.44 1.06 E09 5214.7 1.08 1.01 1.14 1.40 E02
DD1Y 1.26 1.13 1.39 1.17 E05 5576.7 1.05 0.98 1.12 2.00 E01
D2Y 1.08 0.99 1.18 6.56 E02 5385.9 1.00 0.95 1.06 9.12 E01
DD2Y 1.32 1.17 1.48 2.74 E06 5672.7 1.08 1.00 1.17 4.77 E02
Crude results for rs601338 Results for rs601338 conditioned to rs8111874
Marker rs_number EA NEA EAF IMP Outcome OR lCI uCI P-value OR lCI uCI P-value
19:49206674:SNP rs601338 G (W) A (X) 0.52 1 D1Y 1.28 1.18 1.39 2.74 E09 6224.8 1.06 1.00 1.12 3.93 E02
DD1Y 1.25 1.14 1.37 1.99 E06 6872.8 1.07 1.01 1.14 2.48 E02
D2Y 1.10 1.02 1.18 1.84 E02 6471.1 1.04 0.99 1.09 1.40 E01
DD2Y 1.27 1.14 1.4 5.90 E06 6976.7 1.06 0.99 1.13 1.16 E01
EA: effect allele; NEA: non effect allele; EAF: effect allele frequency; IMP: imputation quality (from–to); D1Y: any diarrhoea at age one year; DD1Y: doctor’s confirmed di-
agnosis of diarrhoea at age 1 year; D2Y any diarrhoea at age two years; DD2y doctor’s confirmed diagnosis of diarrhoea at age 2 years. Distance between SNPs is 37.7 kb.
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in childhood (COPSAC2000 and COPSAC2010), the Generation R
study, the Influence of Life-style related factors on the develop-
ment of the Immune System and Allergies in East and West
Germany plus the influence of traffic emissions and genetics
(LISAplus) study, the Study on the influence of Nutrition
Intervention plus Air pollution and Genetic on Allergy develop-
ment (GINIplus), the Infancia y Medio Ambiente (INMA) project
and the national Norwegian Mother and Child Cohort Study
(MoBa). Cohorts were allocated in the discovery or in the repli-
cation set with the aim of making both sets comparable.
Diarrhoeal disease was defined in two different time windows:
around age 1 year (from 0 months to 18 months) and around
age 2 years (from 12 to 30 months). At each time point diarrhoea
(D1Y and D2Y) and doctor diagnosis of diarrhoea (DD1Y and
DD2Y) were studied. Data were collected from parental ques-
tionnaires, doctor interviews or medical records. A detailed de-
scription of diarrhoeal disease definitions in each cohort at each
time point is described in the Supplementary Material, Annex
A. A comparison of the year of initiation of the cohort vs. the
year of introduction of Rotavirus vaccination in each country can
be seen in Supplementary Material, Annex B. The vaccine was
introduced in the USA at the time when children from CHOP
study were enrolled, and thus we excluded vaccinated children,
identified through medical records, from the analysis.
Each cohort obtained the ethical approval from the respec-
tive Ethical Committees and a written consent including per-
mission to perform GWAS analyses was obtained from
participating parents.
Genotyping, quality control and imputation
Genotypes within each cohort were collected using high-
density SNP arrays on Illumina (ALSPAC, CHOP, COPSAC2000,
COPSAC2010, Generation R, INMA_SAB, INMA_VAL, MoBa) and
Affymetrix (GINIplus and LISAplus) platforms. Each cohort im-
puted up to 30 M variants using MACH (68) or IMPUTE2 (69)
considering the 1000 Genomes Project CEU release March 2012
(http://mathgen.stats.ox.ac.uk/impute/ALL_1000G_phase1inte
grated_v3_impute.tgz) as the reference population panel. More
details on the process followed by each cohort are described in
Supplementary Material, Annex A.
Analysis, meta-analysis and replication
The study included only at term Caucasian singletons and chil-
dren with congenital anomalies were excluded. The association
between diarrhoeal disease and the variant dose was assessed
in each study using logistic regression analyses assuming an
additive genetic model. Sex and principal components account-
ing for genetic sub-stratification were added as covariates.
Chromosome X was analysed under the same statistical model
but without sex adjustment. More details on the programs used
by each study to perform the analysis can be found in
Supplementary Material, Annex A.
Only variants with a Minor Allele Frequency (MAF)0.01 and
with a quality of imputation 0.4 (INFO) or 0.3 (R2) were con-
sidered. Due to the limited sample size of some cohorts, an ad-
ditional filtering based on expected minor allele counts (EMAC)
was performed. This parameter is related to both the sample
size and the quality of imputation (2*N*MAF*quality of imputa-
tion). Variants that did not reach an EMAC 50 were excluded.
After quality control, from 5.4 to 8.7 million variants were kept
for the analysis in each cohort. The genomic inflation factor
lambda (k) was calculated for each study. A summary of the
quality control procedure is shown in Supplementary Material,
Table S14. Marker names and alleles were harmonized among
studies.
A fixed effect meta-analysis weighted by inverse variance
was conducted using GWAMA (70). The genomic control ap-
proach was applied to the meta-analysis results. Only variants
with data for at least 5000 samples were considered. Genome-
wide level of significance was defined at P-value 5E08 and
suggestive associations at P-value1E05. Quantile–quantile
(Q–Q) plots, calculation of lambda (k) and Manhattan plots were
performed in R software environment version 3.2.3 (71).
Regional association plots were performed with Locus Zoom
(72).
In total 72 variants were followed for replication in an inde-
pendent dataset. They were selected among the four outcomes
based on the statistical significance (P-value< 1E05).
Association P-values from the replication phase were corrected
for multiple testing using Bonferroni correction (for each trait
independently). Exclusion of CHOP cohort, as it comprises po-
tentially vaccinated children, from the replication phase did not
revealed any new replicated genetic variant, and the association
of replicated variants was maintained (data not shown).
Conditional analysis
We conditioned the analysis of the leading SNP identified at
19q13.33 (rs8111874) to a stop mutation situated 37.7 kb apart
(rs601338, W154X) using the GCTA program (73). As reference,
we used the INMA 1000 Genomes imputation [restricted to vari-
ants with MAF> 0.01 and imputation quality (INFO)>0.8].
A similar analysis was performed to search for secondary
signals in 6500 kb surrounding the stop mutation (rs601338) or
the top SNP at 19q13.33 (rs8111874). In this case, the significance
threshold was calculated by Bonferroni correction, where the
number of independent tests was the effective number of vari-
ants in this region estimated using Nyholt’s procedure and the
1000G reference data for Europeans (74).
Annotation and enrichment analysis
Genetic variants annotation (nearest gene, eQTLs, protein bind-
ing, and regulatory features) was done with the HaploReg v4.1
program (75). In addition, a second search for eQTLs and for ex-
pression levels in tissues was performed with Genotype-Tissue
Expression (GTEx) data (http://www.gtexportal.org/; date last
accessed July 2016). GeneCard (http://www.genecards.org; date
last accessed July 2016) and the USC genome browser (http://ge
nome.ucsc.edu/; date last accessed July 2016) were used to
search for gene functions and GWAS signals, respectively.
Two different tools were used to explore gene-set enrich-
ment analysis. We performed an analysis with MAGENTA soft-
ware that uses genome-wide summary statistics (76). Briefly,
first, the program links variants to genes considering flanking
regions and then computes the gene-set enrichment comparing
the variants with the lowest P-values (95th percentile) versus
the rest. Gene-set databases evaluated in MAGENTA were
Panther, KEGG (Kyoto Encyclopaedia of Genes and Genomes)
and Ingenuity. In addition, we used DEPICT to identify enriched
genes-sets as well as tissues/cell types where genes from asso-
ciated loci are highly expressed (77). In this case, only variants
associated with diarrhoea with a P-value  1E05 and a sample
size>5000 were considered. Both programs estimate adjusted
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P-values using the FDR method. In the case of MAGENTA, FDR
was applied within each database.
Overlap with known variants and genes for related
diseases
We investigated the association between diarrhoea and known
variants for inflammatory bowel disease (IBD) (22). We also
looked at variants associated with viral infection susceptibility,
disease progression and response to vaccination against differ-
ent viruses (23–36). Variants were selected from GWAS retrieved
from the GWAS catalog (http://www.ebi.ac.uk/gwas/, April
2015). All variants reported in European populations, regardless
of their statistical significance, and their replication status,
were evaluated. Finally, we evaluated 86 genes retrieved from
OMIM (Online Mendelian Inheritance in Man; July 2016) with the
entry ‘diarrhoea’. To test the association of these ‘candidate’
genes, we performed a gene-based analysis using VEGAS2
(Versatile Gene based Association Study, http://vegas2.qimr
berghofer.edu.au/) (78), considering linkage disequilibrium pat-
terns described in European populations and a flanking region
of 650 kb around the gene. The corrected statistical significance
level was calculated using Bonferroni correction accounting for
the number of variants/genes within each analysis (inflamma-
tory bowel disease, viral infection, or hereditary diarrhoeal dis-
eases) as independent tests.
Genome-wide summarized results of the discovery phase can
be found at INMA’s web page (Infancia and Medio Ambiente
project, http://www.proyectoinma.org/) and at the EAGLE con-
sortium web page (http://www.wikigenes.org/e/art/e/348.html).
Supplementary Material
Supplementary Material is available at HMG online.
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